Sculptor Capital LP Vaxart, Inc. Transaction History

Sculptor Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.29 - $6.64 $309,738 - $479,408	-72,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $16,698 - $35,574	3,300 Added 4.79%	72,200 $541,000
Q1 2021 May 14, 2021	SELL	$5.64 - $23.33 $360,960 - $1.49 Million	-64,000 Reduced 48.16%	68,900 $417,000
Q4 2020 Feb 16, 2021	SELL	$3.5 - $7.98 $3,850 - $8,778	-1,100 Reduced 0.82%	132,900 $758,000
Q3 2020 Nov 12, 2020	BUY	$4.78 - $16.97 $640,520 - $2.27 Million	134,000 New	134,000 $891,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.